About: http://data.cimple.eu/news-article/2aaa5c52215b72fc8fc524e1add0b73a6b0e8c77ae22740a0509dd4a     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • A court on Thursday ordered the French state to pay tens of thousands of euros in damages after finding it responsible in a case over birth defects linked to an anti-epilepsy drug made by pharmaceutical giant Sanofi. The French court ordered the state to compensate three families who filed complaints after the women took the medicine and gave birth to children with congenital malformations, autism or learning difficulties. The court ruled that Sanofi and doctors who prescribed the drug Depakine were also responsible, in a scandal that has affected 15,000 to 30,000 children, studies have found. The state has been ordered to compensate the three families 20,000 to 290,000 euros ($22,500-$327,000), depending on the date of birth of the five children, now aged between 11 and 35. "The state has neglected its duties to monitor (drugs)," the court said in a statement. "I welcome the conviction of the state, which we were expecting," said Marine Martin, president of the APESAC association that represents 7,000 victims' families. "But I'm angry because 80 percent of the children born before 2004 are excluded from compensation," she said, adding that autism means the children are disabled for life. Depakine is Sanofi's brand name for sodium valproate, which has been used worldwide since the 1960s. Besides epilepsy, it is also used to treat migraines and bipolar disorder. During the hearing last Wednesday, the court's advisory expert said the state knew about the risks regarding malformations from using Depakine starting in 1983, and for learning disabilities and autism from 2004. In a case of a child born in 1985, the court followed the expert and ruled that the risks of physical defects were known and should have alerted the authorities, but that the risks of autism were not clear at the time. As a result, the three families are appealing the court's ruling, the families' lawyer Charles Joseph-Oudin told AFP. Sanofi is facing separate charges of aggravated fraud and unintentionally causing injury, though under the French legal system the charges do not automatically mean the case will reach a courtroom, since prosecutors could decide not to move to trial. The company has denied any wrongdoing, saying it warned health authorities of the drug's risks beginning in the 1980s. fan-ech/sjw/txw
schema:headline
  • French court finds state responsible over drug linked to birth defects
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software